Michael D. Leitl

Michael D. Leitl

Auto-generated profile, based on publicly available information

Michael D. Leitl

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2010 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
JKJerzy Karczewski
Jerzy Karczewski
RSRobert H Spencer
Robert H Spencer
VGVictor M Garsky
Victor M Garsky
ALAnnie Liang
Annie Liang
MLMichael D Leitl
Michael D Leitl
MUMark O Urban
Mark O Urban
BACKGROUND AND PURPOSE Inflammatory pain is triggered by activation of pathways leading to the release of mediators such as bradykinin, prostaglandins, interleukins, ATP, growth factors and protons that sensitize peripheral nociceptors. The activation of acid‐sensitive ion channels (ASICs) may have particular relevance in the development and maintenance of inflammatory pain. ASIC3 is of particular interest due to its restricted tissue distribution in the nociceptive primary afferent fibres and its high sensitivity to protons.EXPERIMENTAL APPROACH To examine the contribution of ASIC3 to the development and maintenance of muscle pain and inflammatory pain, we studied the in vivo efficacy of a selective ASIC3 inhibitor, APETx2, in rats.KEY RESULTS Administration of APETx2 into the gastrocnemius muscle prior to the administration of low pH saline prevented the development of mechanical hypersensitivity, whereas APETx2 administration following low‐pH saline was ineffective in reversing hypersensitivity. The prevention of mechanical hypersensitivity produced by acid administration was observed whether APETx2 was applied via i.m. or i.t. routes. In the complete Freund's adjuvant (CFA) inflammatory pain model, local administration of APETx2 resulted in a potent and complete reversal of established mechanical hypersensitivity, whereas i.t. application of APETx2 was ineffective.CONCLUSIONS AND IMPLICATIONS ASIC3 contributed to the development of mechanical hypersensitivity in the acid‐induced muscle pain model, whereas ASIC3 contributed to the maintenance of mechanical hypersensitivity in the CFA inflammatory pain model. The contribution of ASIC3 to established hypersensitivity associated with inflammation suggests that this channel may be an effective analgesic target for inflammatory pain states.

1 February 2008 in NeuroImage
Verified
Journal Article
Closed access
MSMerav Sabri
Merav Sabri
JBJeffrey R. Binder
Jeffrey R. Binder
RDRutvik H. Desai
Rutvik H. Desai
DMDavid A. Medler
David A. Medler
MLMichael D. Leitl
Michael D. Leitl
ELEinat Liebenthal
Einat Liebenthal

1 June 2015 in Pain
Verified
Journal Article
Closed access
SNS. Stevens Negus
S. Stevens Negus
BNBradley Neddenriep
Bradley Neddenriep
AAAhmad A. Altarifi
Ahmad A. Altarifi
FCF. Ivy Carroll
F. Ivy Carroll
MLMichael D. Leitl
Michael D. Leitl
LMLaurence L. Miller
Laurence L. Miller
Pain-related functional impairment and behavioral depression are diagnostic indicators of pain and targets for its treatment. Nesting is an innate behavior in mice that may be sensitive to pain manipulations and responsive to analgesics. The goal of this study was to develop and validate a procedure for evaluation of pain-related depression of nesting in mice. Male ICR mice were individually housed and tested in their home cages. On test days, a 5- × 5-cm Nestlet was subdivided into 6 pieces, the pieces were evenly distributed on the cage floor, and Nestlet consolidation was quantified during 100-minute sessions. Baseline nesting was stable within and between subjects, and nesting was depressed by 2 commonly used inflammatory pain stimuli (intraperitoneal injection of dilute acid; intraplantar injection of complete Freund adjuvant). Pain-related depression of nesting was alleviated by drugs from 2 classes of clinically effective analgesics (the nonsteroidal anti-inflammatory drug ketoprofen and the μ-opioid receptor agonist morphine) but not by a drug from a class that has failed to yield effective analgesics (the centrally acting kappa opioid agonist U69,593). Neither ketoprofen nor morphine alleviated depression of nesting by U69,593, which suggests that ketoprofen and morphine effects were selective for pain-related depression of nesting. In contrast to ketoprofen and morphine, the kappa opioid receptor antagonist JDTic blocked depression of nesting by U69,593 but not by acid or complete Freund adjuvant. These results support utility of this procedure to assess expression and treatment of pain-related depression in mice.

6 September 2013 in Neuropsychopharmacology
Verified
Journal Article
Closed access
MLMichael D Leitl
Michael D Leitl
SOSara Onvani
Sara Onvani
MBM Scott Bowers
M Scott Bowers
KCKejun Cheng
Kejun Cheng
KRKenner C Rice
Kenner C Rice
SNS Stevens Negus
S Stevens Negus

1 January 2008 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RCRebecca M. Craft
Rebecca M. Craft
MLMichael D. Leitl
Michael D. Leitl

1 January 2014 in Molecular Pain
Verified
Journal Article
Open access
MLMichael D Leitl
Michael D Leitl
DPDavid N Potter
David N Potter
KCKejun Cheng
Kejun Cheng
KRKenner C Rice
Kenner C Rice
WCWilliam A Carlezon
William A Carlezon
SNS Stevens Negus
S Stevens Negus
Background: Intraplantar administration of complete Freund's adjuvant (CFA) and formalin are two noxious stimuli commonly used to produce sustained pain-related behaviors in rodents for research on neurobiology and treatment of pain. One clinically relevant manifestation of pain is depression of behavior and mood. This study compared effects of intraplantar CFA and formalin on depression of positively reinforced operant behavior in an assay of intracranial self-stimulation (ICSS) in rats. Effects of CFA and formalin on other physiological and behavioral measures, and opioid effects on formalin-induced depression of ICSS, were also examined. Results: There were four main findings. First, consistent with previous studies, both CFA and formalin produced similar paw swelling and mechanical hypersensitivity. Second, CFA produced weak and transient depression of ICSS, whereas formalin produced a more robust and sustained depression of ICSS that lasted at least 14 days. Third, formalin-induced depression of ICSS was reversed by morphine doses that did not significantly alter ICSS in saline-treated rats, suggesting that formalin effects on ICSS can be interpreted as an example of pain-related and analgesic-reversible depression of behavior. Finally, formalin-induced depression of ICSS was not associated with changes in central biomarkers for activation of endogenous kappa opioid systems, which have been implicated in depressive-like states in rodents, nor was it blocked by the kappa antagonist norbinaltorphimine. Conclusions: These results suggest differential efficacy of sustained pain stimuli to depress brain reward function in rats as assessed with ICSS. Formalin-induced depression of ICSS does not appear to engage brain kappa opioid systems.